Reimbursement Liaison
Glaukos
Reimbursement Liaison
Glaukos
Medical devices for glaucoma treatment
GLAUKOS – REIMBURSEMENT LIAISON (GLAUCOMA) - HOUSTON, TX | MEMPHIS, TN | RALEIGH, NC
"We'll Go First" (https://youtu.be/wGONQxyEpvs)
How will you make an impact?
The Reimbursement Liaison will serve as an expert in reimbursement policies, as well as patient and provider support, to ensure patients have access to Glaukos’ sight saving technologies.
The Reimbursement Liaison works with physician practices (both private and hospital affiliated institutions). They interact directly with key management personnel, providers and staff members to assure patient access to care. This individual appropriately educates HCPs and their office staff on clinical documentation, securing treatment approvals, patient tracking, claim submission, reconciliation management, patient education, drug inventory, patient copay assistance and drug acquisition channels. This position helps HCPs understand barriers that may impede or delay appropriate patient access to treatment and/or prevent optimal patient outcomes. Additionally, the Reimbursement Liaison provides education on appropriate and accurate billing and coding practices for Glaukos’ products in line with payer requirements to the highest levels of specificity.
This candidate must be organized and detail oriented. Demonstrated teamwork and collaboration abilities with high emotional intelligence in managing multiple business initiatives and cross-functional relationships will be a requirement.
What will you do?
Specific responsibilities include but are not limited to:
The Reimbursement Liaison consistently demonstrates uncompromised ethics and integrity while helping others understand legal and regulatory parameters related to anti-kickback statutes, fraud and abuse, off-label promotion, and OIG guidance related to patient assistance programs.
How will you get here?
#GKOSUS
#LI-Remote
Job Salary Range: 143,400 - 179,200
Glaukos focuses on ophthalmology by developing and commercializing medical devices and therapies for glaucoma, corneal disorders, and retinal diseases. Its products mainly target surgeons who treat eye conditions, with a core technology in micro invasive glaucoma surgery (MIGS). The company’s MIGS devices, such as the Trabecular Micro Bypass Stent and next-generation iStent, are implanted in the eye to improve outflow of eye fluid and lower intraocular pressure, offering a less invasive option compared with traditional surgeries. Glaukos differentiates itself by pioneering MIGS and bringing the first US-approved MIGS device to market in 2012, continuing to expand its portfolio through research, development, and strategic acquisitions. The company aims to improve patient care by providing safer, effective, and longer-lasting treatment options for glaucoma and related eye diseases, addressing unmet needs in ophthalmology.
Explore more opportunities at Glaukos